Evidence that cytokines play a role in rheumatoid arthritis

被引:937
作者
Brennan, Fionula M. [1 ]
McInnes, Iain B. [2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London W6 8LH, England
[2] Univ Glasgow, Ctr Rheumat Dis, Div Immunol Infect & Inflammat, Glasgow, Lanark, Scotland
关键词
D O I
10.1172/JCI36389
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A large number of cytokines are active in the joints of patients with rheumatoid arthritis (RA). It is now clear that these cytokines play a fundamental role in the processes that cause inflammation, articular destruction, and the comorbidities associated with RA. Following the success of TNF-alpha blockade as a treatment for RA, other cytokines now offer alternative targets for therapeutic intervention or might be useful as predictive biomarkers of disease. In this Review, we discuss the biologic contribution and therapeutic potential of the major cytokine families to RA pathology, focusing on molecules contained within the TNF-alpha, IL-1, IL-6, IL-23, and IL-2 families.
引用
收藏
页码:3537 / 3545
页数:9
相关论文
共 130 条
  • [21] Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO
  • [22] 2-E
  • [23] INDUCTION OF INTERFERON-GAMMA PRODUCTION BY NATURAL-KILLER-CELL STIMULATORY FACTOR - CHARACTERIZATION OF THE RESPONDER CELLS AND SYNERGY WITH OTHER INDUCERS
    CHAN, SH
    PERUSSIA, B
    GUPTA, JW
    KOBAYASHI, M
    POSPISIL, M
    YOUNG, HW
    WOLF, SF
    YOUNG, D
    CLARK, SC
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) : 869 - 879
  • [24] Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis - A randomized, double-blind, placebo-controlled, dose-escalation trial
    Choy, EHS
    Isenberg, DA
    Garrood, T
    Farrow, S
    Ioannou, Y
    Bird, H
    Cheung, N
    Williams, B
    Hazleman, B
    Price, R
    Yoshizaki, K
    Nishimoto, N
    Kishimoto, T
    Panayi, GS
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3143 - 3150
  • [25] LOCALIZATION OF TUMOR-NECROSIS-FACTOR-ALPHA IN SYNOVIAL TISSUES AND AT THE CARTILAGE PANNUS JUNCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    CHU, CQ
    FIELD, M
    FELDMANN, M
    MAINI, RN
    [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (09): : 1125 - 1132
  • [26] Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis
    Cohen, Stanley B.
    Dore, Robin K.
    Lane, Nancy E.
    Ory, Peter A.
    Peterfy, Charles G.
    Sharp, John T.
    van der Heijde, Desiree
    Zhou, Lifen
    Tsuji, Wayne
    Newmark, Richard
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (05): : 1299 - 1309
  • [27] Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
    Cua, DJ
    Sherlock, J
    Chen, Y
    Murphy, CA
    Joyce, B
    Seymour, B
    Lucian, L
    To, W
    Kwan, S
    Churakova, T
    Zurawski, S
    Wiekowski, M
    Lira, SA
    Gorman, D
    Kastelein, RA
    Sedgwick, JD
    [J]. NATURE, 2003, 421 (6924) : 744 - 748
  • [28] The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis
    Dayer, JM
    [J]. RHEUMATOLOGY, 2003, 42 : 3 - 10
  • [29] CACHECTIN TUMOR NECROSIS FACTOR STIMULATES COLLAGENASE AND PROSTAGLANDIN-E2 PRODUCTION BY HUMAN SYNOVIAL-CELLS AND DERMAL FIBROBLASTS
    DAYER, JM
    BEUTLER, B
    CERAMI, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (06) : 2163 - 2168
  • [30] LOCALIZATION OF TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SYNOVIAL TISSUE AND CARTILAGE PANNUS JUNCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS - IMPLICATIONS FOR LOCAL ACTIONS OF TUMOR-NECROSIS-FACTOR-ALPHA
    DELEURAN, BW
    CHU, CQ
    FIELD, M
    BRENNAN, FM
    MITCHELL, T
    FELDMANN, M
    MAINI, RN
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (10): : 1170 - 1178